Cyclosporine enhances platelet procoagulant activity

Area of Science:

• Biochemistry
• Hematology
• Immunology

Background:

• Cyclosporine (CsA) use is linked to thromboembolic events.
• Underlying molecular mechanisms require elucidation.

Purpose of the Study:

• Investigate if CsA induces platelet procoagulant activity.
• Examine CsA's interaction with platelet membranes, phosphatidylserine (PS) exposure, and thrombin generation.

Main Methods:

• In vitro platelet treatment with CsA.
• Assay of platelet procoagulant activity (thrombin generation).
• Flow cytometry analysis of platelet morphology and PS exposure using annexin V.

Main Results:

• CsA potentiates collagen-induced platelet procoagulant response.
• CsA treatment increases PS externalization in platelets.
• CsA alters platelet scatter properties and releases lactate dehydrogenase.

Conclusions:

• CsA's thrombogenic potential may stem from altered platelet membrane lipid organization.
• Externalization of PS and accelerated thrombin generation contribute to CsA-induced thrombogenicity.